The featured report from GMO’s Asset Allocation team examines how AI enthusiasm is distorting equity valuations and challenging disciplined investment frameworks.
-
Over 30% of U.S. market capitalization now trades above 10× sales, a level historically associated with late-cycle excess and prior market bubbles.
-
Valuation pressure is not confined to a few mega-caps; equal-weighted data show a broad expansion of speculative pricing across the market.
-
High expectations leave little margin for error, raising the risk of sharp corrections even for high-quality companies.
How should investors recalibrate return assumptions when optimism, not fundamentals, is setting the price?
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
